- Overview
-
Dr. Amanda Li graduated from Dalhousie University medical school in 2010, and completed her Pediatrics residency and Pediatric Hematology-Oncology fellowship at the University of British Columbia. Following this, she trained at the Children’s Hospital of Philadelphia in the field of Cancer Immunotherapy and Bone Marrow Transplant, with a clinical and research focus on using genetically engineered cell therapies in the treatment of hematologic malignancies.
New research funding to accelerate stem cell-based therapies for type 1 diabetes at BC Children’s Hospital
BC Children’s Hospital’s Dr. Francis Lynn is leading one of two groups awarded a total of $6 million in funding from the Government of Canada and JDRF Canada to accelerate the development of stem cell based therapies for type 1 diabetes (T1D)